Breast Cancer

Genomics can improve patients outcomes in metastatic breast cancer – with the right tools

Genomics can help guide treatment and improve outcomes in metastatic breast cancer patients, but only if interpreted with a validated framework of actionability, oncologists have told the 2021 San Antonio Breast Cancer Symposium. A study presented by Dr Fabrice André, research director at Gustave Roussy Cancer Campus, Paris, which assessed the efficacy of therapies in ...

Already a member?

Login to keep reading.

© 2022 the limbic